News

Challenge Theme – iPSCsChallenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cells
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Regulatory Round-up - August 2023Regulatory Round-up - August 2023Cell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult to support FourPlus in testing its immersive technology training platformCell and Gene Therapy Catapult to support FourPlus in testing its immersive technology training platformPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesRegulatory Round-up - July 2023Regulatory Round-up - July 2023Cell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business OfficerCell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business OfficerCell and Gene Therapy Catapult to support the development of NK:IO’s natural killer cell therapyCell and Gene Therapy Catapult to support the development of NK:IO’s natural killer cell therapyThe Advanced Therapies Apprenticeship Community welcomes its 300th apprenticeThe Advanced Therapies Apprenticeship Community welcomes its 300th apprenticeRegulatory Round-up - June 2023Regulatory Round-up - June 2023Cell and Gene Therapy Catapult nominated for Innovation of the Year Award at the British Training AwardsCell and Gene Therapy Catapult nominated for Innovation of the Year Award at the British Training AwardsAutolomous and the Cell and Gene Therapy Catapult awarded £1.2m grant by UK Research and InnovationAutolomous and the Cell and Gene Therapy Catapult awarded £1.2m grant by UK Research and InnovationCell and Gene Therapy Catapult opens new laboratories and offices in Edinburgh BioQuarterCell and Gene Therapy Catapult opens new laboratories and offices in Edinburgh BioQuarter